A case of difficult-to-treat eosinophilic asthma controlled with clarithromycin

Annals of Allergy, Asthma and Immunology

Volumn 109, Issue 1, 2012, Pages 82-83

  Morisset, Julie ^a,b   Ptaszynski, Stanislaw ^a   Al Mot, Sawsan ^a   Dubois, Yvon ^a   Bergeron, Céline ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CICLESONIDE; CLARITHROMYCIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MOXIFLOXACIN; PREDNISONE; SALBUTAMOL; TIOTROPIUM BROMIDE; ZAFIRLUKAST;

ABSENCE OF SIDE EFFECTS; AGED; ASTHMA; CASE REPORT; CHRONIC SINUSITIS; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; EOSINOPHIL COUNT; EOSINOPHILIC ASTHMA; FORCED EXPIRATORY VOLUME; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; LETTER; MALE; PRIORITY JOURNAL;

EID: 84862873018     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2012.05.010     Document Type: Article

References (8)

1. Dolan CM, Fraher KE, Bleecker ER, et al. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-totreat asthma. Ann Allergy Asthma Immunol. 2004;92:32-39. (Pubitemid 38113629)
2. Tough SC, Hessel PA, Ruff M, Green FH, Mitchell I, Butt JC. Features that distinguish those who die from asthma from community controls with asthma. J Asthma. 1998;35:657-665. (Pubitemid 29015373)
3. Van Ganse E, Laforest L, Pietri G, et al. Persistent asthma: disease control, resource utilisation and direct costs. Eur Respir J. 2002;20:260-267.
4. Friedlander AL, Albert RK. Chronic macrolide therapy in inflammatory airways diseases. Chest. 2010;138:1202-1212.
5. Shinkai M, Henke MO, Rubin BK. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action. Pharmacol Ther. 2008;117:393-405.
6. Kohyama T, Takizawa H, Kawasaki S, Akiyama N, Sato M, Ito K. Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. Antimicrob Agents Chemother. 1999;43:907-911. (Pubitemid 29165756)
7. Adachi T, Motojima S, Hirata A, et al. Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5. J Allergy Clin Immunol. 1996;98(6 pt 2):S207-S215.
8. Albert RK, Connett J, Bailey WC, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011;365:689-698.